News
09-06-2016, 06:19 AM
NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB) stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using the Xoft Axxent electronic brachytherapy system with ORL managed service as a treatment option for early stage breast cancer patients.
More... (http://www.news-medical.net/news/20160906/NICE-MIB-offers-SD-IORT-using-Xoft-Axxent-electronic-brachytherapy-system-for-early-stage-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20160906/NICE-MIB-offers-SD-IORT-using-Xoft-Axxent-electronic-brachytherapy-system-for-early-stage-breast-cancer-patients.aspx)